Eric M. Lindenfeld is a member of the firm’s Mass Tort Practice Group who focuses his practice on representing individuals who have been harmed by defective pharmaceutical and medical device products. Eric has experience in all phases of mass tort litigation, including trial practice, motion practice, conducting depositions, and written discovery.
Eric earned his law degree, with honors, from the University of Minnesota. While attending law school, he won awards for outstanding written advocacy in various moot court competitions. He has also authored several scholarly articles on cutting-edge and developing topics in mass tort litigation.
His publications have been widely cited by law professors and practitioners, including in the Law, Medicine & Medical Technology and the Food and Drug Administration casebooks.
In his free time, Eric enjoys hiking, watching mind-bending documentaries, playing with his dogs Stella and Annie, and of course, watching the Knicks win basketball games, which is rare.